Symbols / NEO
NEO Chart
About
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company offers molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 1.25B |
| Enterprise Value | 1.50B | Income | -108.03M | Sales | 727.33M |
| Book/sh | 6.49 | Cash/sh | 1.23 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2500 | IPO | — |
| P/E | — | Forward P/E | 30.24 | PEG | — |
| P/S | 1.72 | P/B | 1.49 | P/C | — |
| EV/EBITDA | -825.11 | EV/Sales | 2.07 | Quick Ratio | 3.61 |
| Current Ratio | 4.26 | Debt/Eq | 48.95 | LT Debt/Eq | — |
| EPS (ttm) | -0.84 | EPS next Y | 0.32 | EPS Growth | — |
| Revenue Growth | 10.60% | Earnings | 2026-04-28 | ROA | -2.90% |
| ROE | -12.43% | ROIC | — | Gross Margin | 43.16% |
| Oper. Margin | -6.56% | Profit Margin | -14.85% | Shs Outstand | 129.81M |
| Shs Float | 119.39M | Short Float | 10.67% | Short Ratio | 5.12 |
| Short Interest | — | 52W High | 13.74 | 52W Low | 4.72 |
| Beta | 1.58 | Avg Volume | 1.87M | Volume | 1.78M |
| Target Price | $14.81 | Recom | Buy | Prev Close | $9.97 |
| Price | $9.65 | Change | -3.21% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$14.81
Mean price target
2. Current target
$9.65
Latest analyst target
3. DCF / Fair value
$2.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.65
Low
$13.00
High
$17.00
Mean
$14.81
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-24 | main | Piper Sandler | Overweight → Overweight | $13 |
| 2026-02-17 | main | Needham | Buy → Buy | $15 |
| 2026-01-12 | reit | Needham | Buy → Buy | $14 |
| 2025-09-12 | main | TD Cowen | Buy → Buy | $12 |
| 2025-09-02 | main | Stephens & Co. | Overweight → Overweight | $11 |
| 2025-08-29 | main | Needham | Buy → Buy | $14 |
| 2025-08-04 | main | Piper Sandler | Overweight → Overweight | $11 |
| 2025-07-30 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $8 |
| 2025-07-29 | down | William Blair | Outperform → Market Perform | — |
| 2025-07-29 | main | Needham | Buy → Buy | $8 |
| 2025-05-06 | main | Piper Sandler | Overweight → Overweight | $12 |
| 2025-05-01 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $10 |
| 2025-04-30 | main | Goldman Sachs | Buy → Buy | $10 |
| 2025-04-30 | down | Leerink Partners | Outperform → Market Perform | $9 |
| 2025-04-29 | main | Needham | Buy → Buy | $9 |
| 2025-04-17 | main | Goldman Sachs | Buy → Buy | $15 |
| 2025-02-26 | main | Piper Sandler | Overweight → Overweight | $18 |
| 2025-02-19 | main | B of A Securities | Neutral → Neutral | $16 |
| 2025-02-19 | main | Needham | Buy → Buy | $18 |
| 2025-01-28 | main | Goldman Sachs | Buy → Buy | $18 |
News
RSS: Latest NEO news- When the Price of (NEO) Talks, People Listen (NEO:CA) - Stock Traders Daily Wed, 25 Feb 2026 01
- Apparel supplier Neo-Concept raises ~$8M to expand its business - Stock Titan ue, 24 Feb 2026 21
- NeoGenomics, Inc. (NEO) Stock Analysis: A 47% Upside Potential in the Healthcare Diagnostics Sector - DirectorsTalk Interviews ue, 24 Feb 2026 14
- Assessing NeoGenomics (NEO) Valuation After Earnings Growth, Wider Annual Loss And New Guidance - simplywall.st ue, 24 Feb 2026 16
- NeoGenomics, Inc. $NEO Stock Holdings Lifted by Aberdeen Group plc - MarketBeat Sat, 21 Feb 2026 08
- Why NeoGenomics (NEO) Shares Are Falling Today - Yahoo Finance Wed, 18 Feb 2026 20
- $NEO stock is down 10% today. Here's what we see in our data. - Quiver Quantitative Wed, 18 Feb 2026 19
- Why Neo Performance Materials Stock Is Breaking Out - TipRanks Fri, 20 Feb 2026 18
- NeoGenomics, Inc. $NEO Shares Bought by White Pine Capital LLC - MarketBeat Sat, 21 Feb 2026 14
- Backblaze targets $236.53B AI neocloud boom with new B2 Neo storage - Stock Titan Mon, 23 Feb 2026 14
- Assessing NeoGenomics (NEO) Valuation After Recent Share Price Weakness - Yahoo Finance Mon, 23 Feb 2026 04
- Hong Kong apparel supplier Neo-Concept raises $8.1M in US share sale - Stock Titan Wed, 11 Feb 2026 08
- Neo Performance Materials (OTCMKTS:NOPMF) Shares Up 7.7% - What's Next? - MarketBeat Sat, 21 Feb 2026 00
- Why NeoGenomics (NEO) Stock Is Trading Up Today - Yahoo Finance ue, 28 Oct 2025 07
- Stream NeoGenomics' March oncology diagnostics talks from two investor events - Stock Titan Wed, 18 Feb 2026 12
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 22128 | 276682.0 | — | Sale at price 12.50 per share. | STONE WARREN | President | — | 2026-01-20 00:00:00 | D |
| 1 | 59382 | nan | — | — | OLIVO ALICIA C | General Counsel | — | 2026-01-13 00:00:00 | D |
| 2 | 59382 | nan | — | — | STONE WARREN | President | — | 2026-01-13 00:00:00 | D |
| 3 | 20916 | 250992.0 | — | Sale at price 12.00 per share. | OLIVO ALICIA C | General Counsel | — | 2025-11-25 00:00:00 | D |
| 4 | 8977 | 90219.0 | — | Conversion of Exercise of derivative security at price 10.05 per share. | OLIVO ALICIA C | General Counsel | — | 2025-11-25 00:00:00 | D |
| 5 | 4918 | 49180.0 | — | Sale at price 10.00 per share. | OLIVO ALICIA C | Officer | — | 2025-10-16 00:00:00 | D |
| 6 | 20000 | 112322.0 | — | Purchase at price 5.62 per share. | SHERMAN JEFFREY SCOTT | Chief Financial Officer | — | 2025-08-06 00:00:00 | D |
| 7 | 17900 | 99954.0 | — | Purchase at price 5.58 per share. | ZOOK ANTHONY P | Chief Executive Officer | — | 2025-08-06 00:00:00 | D |
| 8 | 12254 | nan | — | — | ZOOK ANTHONY P | Chief Executive Officer | — | 2025-05-30 00:00:00 | D |
| 9 | 12254 | nan | — | — | HANNAH ALISON L. | Director | — | 2025-05-30 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -161.12K | -1.04M | -427.21K | 0.00 |
| TaxRateForCalcs | 0.02 | 0.09 | 0.09 | 0.27 |
| NormalizedEBITDA | 5.15M | -6.52M | -77.81M | 46.50M |
| TotalUnusualItems | -6.66M | -11.09M | -4.52M | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -6.66M | -11.09M | -4.52M | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -78.73M | -87.97M | -144.25M | -8.35M |
| ReconciledDepreciation | 72.55M | 72.58M | 69.43M | 53.35M |
| ReconciledCostOfRevenue | 331.81M | 308.44M | 285.17M | 297.27M |
| EBITDA | -1.51M | -17.61M | -82.33M | 46.50M |
| EBIT | -74.06M | -90.19M | -151.76M | -6.86M |
| NetInterestIncome | 11.81M | 9.99M | -1.51M | -5.08M |
| InterestExpense | 6.62M | 6.91M | 7.58M | 8.22M |
| InterestIncome | 18.43M | 16.90M | 6.08M | 3.14M |
| NormalizedIncome | -72.23M | -77.92M | -140.16M | -8.35M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -78.73M | -87.97M | -144.25M | -8.35M |
| TotalExpenses | 746.01M | 688.29M | 662.84M | 603.08M |
| TotalOperatingIncomeAsReported | -92.11M | -107.74M | -157.62M | -118.75M |
| DilutedAverageShares | 126.66M | 125.50M | 124.22M | 119.96M |
| BasicAverageShares | 126.66M | 125.50M | 124.22M | 119.96M |
| DilutedEPS | -0.62 | -0.70 | -1.16 | -0.07 |
| BasicEPS | -0.62 | -0.70 | -1.16 | -0.07 |
| DilutedNIAvailtoComStockholders | -78.73M | -87.97M | -144.25M | -8.35M |
| NetIncomeCommonStockholders | -78.73M | -87.97M | -144.25M | -8.35M |
| NetIncome | -78.73M | -87.97M | -144.25M | -8.35M |
| NetIncomeIncludingNoncontrollingInterests | -78.73M | -87.97M | -144.25M | -8.35M |
| NetIncomeContinuousOperations | -78.73M | -87.97M | -144.25M | -8.35M |
| TaxProvision | -1.95M | -9.13M | -15.09M | -6.73M |
| PretaxIncome | -80.67M | -97.10M | -159.34M | -15.07M |
| OtherIncomeExpense | -7.04M | -10.44M | -4.73M | 108.76M |
| OtherNonOperatingIncomeExpenses | -379.00K | 644.00K | -213.00K | -499.00K |
| SpecialIncomeCharges | -6.66M | -11.09M | -4.52M | 0.00 |
| RestructuringAndMergernAcquisition | 6.66M | 11.09M | 4.52M | 0.00 |
| EarningsFromEquityInterest | 0.00 | 0.00 | 109.26M | |
| NetNonOperatingInterestIncomeExpense | 11.81M | 9.99M | -1.51M | -5.08M |
| InterestExpenseNonOperating | 6.62M | 6.91M | 7.58M | 8.22M |
| InterestIncomeNonOperating | 18.43M | 16.90M | 6.08M | 3.14M |
| OperatingIncome | -85.45M | -96.65M | -153.11M | -118.75M |
| OperatingExpense | 375.55M | 341.25M | 341.00M | 305.81M |
| DepreciationAmortizationDepletionIncomeStatement | 33.90M | 33.98M | 32.77M | |
| DepreciationAndAmortizationInIncomeStatement | 33.90M | 33.98M | 32.77M | |
| Amortization | 13.81M | 15.49M | 14.65M | |
| AmortizationOfIntangiblesIncomeStatement | 13.81M | 15.49M | 14.65M | |
| DepreciationIncomeStatement | 20.09M | 18.49M | 18.12M | |
| ResearchAndDevelopment | 31.16M | 27.31M | 30.33M | 21.87M |
| SellingGeneralAndAdministration | 310.49M | 279.96M | 277.91M | 283.94M |
| SellingAndMarketingExpense | 84.62M | 70.84M | 67.32M | 62.59M |
| GeneralAndAdministrativeExpense | 225.87M | 209.12M | 210.59M | 221.35M |
| OtherGandA | 225.87M | 209.12M | 210.59M | 221.35M |
| GrossProfit | 290.10M | 244.60M | 187.90M | 187.06M |
| CostOfRevenue | 370.47M | 347.04M | 321.83M | 297.27M |
| TotalRevenue | 660.57M | 591.64M | 509.73M | 484.33M |
| OperatingRevenue | 660.57M | 591.64M | 509.73M | 484.33M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 128.15M | 127.37M | 126.91M | 124.11M |
| ShareIssued | 128.15M | 127.37M | 126.91M | 124.11M |
| NetDebt | 174.10M | 195.71M | 272.14M | 215.66M |
| TotalDebt | 605.33M | 611.68M | 610.93M | 612.79M |
| TangibleBookValue | 39.89M | 45.64M | 67.00M | 138.84M |
| InvestedCapital | 1.44B | 1.48B | 1.53B | 1.64B |
| WorkingCapital | 294.78M | 500.51M | 515.36M | 594.28M |
| NetTangibleAssets | 39.89M | 45.64M | 67.00M | 138.84M |
| CapitalLeaseObligations | 64.22M | 73.48M | 75.61M | 80.31M |
| CommonStockEquity | 902.34M | 941.54M | 998.02M | 1.11B |
| TotalCapitalization | 1.24B | 1.48B | 1.53B | 1.64B |
| TotalEquityGrossMinorityInterest | 902.34M | 941.54M | 998.02M | 1.11B |
| StockholdersEquity | 902.34M | 941.54M | 998.02M | 1.11B |
| GainsLossesNotAffectingRetainedEarnings | -206.00K | -1.67M | -3.90M | -638.00K |
| OtherEquityAdjustments | -206.00K | -1.67M | -3.90M | -638.00K |
| RetainedEarnings | -325.78M | -247.06M | -159.09M | -14.84M |
| AdditionalPaidInCapital | 1.23B | 1.19B | 1.16B | 1.12B |
| CapitalStock | 128.00K | 127.00K | 127.00K | 124.00K |
| CommonStock | 128.00K | 127.00K | 127.00K | 124.00K |
| TotalLiabilitiesNetMinorityInterest | 735.70M | 739.69M | 742.01M | 761.50M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 434.46M | 643.39M | 652.08M | 674.27M |
| OtherNonCurrentLiabilities | 11.77M | 13.03M | 13.05M | 14.02M |
| NonCurrentDeferredLiabilities | 21.51M | 24.29M | 34.75M | 55.48M |
| NonCurrentDeferredTaxesLiabilities | 21.51M | 24.29M | 34.75M | 55.48M |
| LongTermDebtAndCapitalLeaseObligation | 401.18M | 606.07M | 604.27M | 604.77M |
| LongTermCapitalLeaseObligation | 60.84M | 67.87M | 68.95M | 72.29M |
| LongTermDebt | 340.33M | 538.20M | 535.32M | 532.48M |
| CurrentLiabilities | 301.24M | 96.30M | 89.93M | 87.23M |
| CurrentDeferredLiabilities | 409.00K | 2.13M | 7.56M | 5.19M |
| CurrentDeferredRevenue | 409.00K | 2.13M | 7.56M | 5.19M |
| CurrentDebtAndCapitalLeaseObligation | 204.16M | 5.61M | 6.65M | 8.02M |
| CurrentCapitalLeaseObligation | 3.38M | 5.61M | 6.65M | 8.02M |
| CurrentDebt | 200.78M | |||
| OtherCurrentBorrowings | 200.78M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 62.44M | 53.16M | 40.14M | 38.30M |
| PayablesAndAccruedExpenses | 34.23M | 35.40M | 35.58M | 35.72M |
| CurrentAccruedExpenses | 12.62M | 15.07M | 15.07M | 17.80M |
| Payables | 21.61M | 20.33M | 20.51M | 17.92M |
| AccountsPayable | 21.61M | 20.33M | 20.51M | 17.92M |
| TotalAssets | 1.64B | 1.68B | 1.74B | 1.87B |
| TotalNonCurrentAssets | 1.04B | 1.08B | 1.13B | 1.19B |
| OtherNonCurrentAssets | 5.89M | 4.74M | 5.11M | 7.17M |
| InvestmentsAndAdvances | 0.00 | |||
| LongTermEquityInvestment | 0.00 | |||
| InvestmentsinAssociatesatCost | 0.00 | |||
| GoodwillAndOtherIntangibleAssets | 862.45M | 895.89M | 931.03M | 969.44M |
| OtherIntangibleAssets | 339.68M | 373.13M | 408.26M | 442.32M |
| Goodwill | 522.77M | 522.77M | 522.77M | 527.12M |
| NetPPE | 173.69M | 183.78M | 198.61M | 211.66M |
| AccumulatedDepreciation | -189.99M | -158.21M | -131.93M | -109.95M |
| GrossPPE | 363.68M | 341.99M | 330.54M | 321.61M |
| Leases | 57.57M | 49.23M | 44.42M | 43.25M |
| ConstructionInProgress | 8.51M | 3.61M | 8.98M | 12.39M |
| OtherProperties | 180.92M | 190.33M | 187.87M | 188.61M |
| MachineryFurnitureEquipment | 116.67M | 98.82M | 89.27M | 77.36M |
| BuildingsAndImprovements | 0.00 | |||
| LandAndImprovements | 0.00 | |||
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 596.02M | 596.81M | 605.29M | 681.51M |
| OtherCurrentAssets | 11.72M | 8.24M | 8.08M | 8.19M |
| AssetsHeldForSaleCurrent | 0.00 | 10.05M | ||
| PrepaidAssets | 20.16M | 17.99M | 15.24M | 12.35M |
| Inventory | 26.75M | 24.16M | 24.28M | 23.39M |
| Receivables | 150.54M | 131.23M | 119.71M | 112.13M |
| AccountsReceivable | 150.54M | 131.23M | 119.71M | 112.13M |
| CashCashEquivalentsAndShortTermInvestments | 386.84M | 415.20M | 437.99M | 515.39M |
| OtherShortTermInvestments | 19.83M | 72.72M | 174.81M | 198.56M |
| CashAndCashEquivalents | 367.01M | 342.49M | 263.18M | 316.83M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -34.04M | -30.70M | -96.88M | -90.86M |
| RepaymentOfDebt | 0.00 | 0.00 | ||
| IssuanceOfDebt | 0.00 | 0.00 | 334.41M | |
| IssuanceOfCapitalStock | 4.65M | 4.62M | 12.59M | 423.21M |
| CapitalExpenditure | -41.06M | -28.75M | -30.89M | -64.14M |
| InterestPaidSupplementalData | 3.83M | 3.38M | 3.40M | 3.06M |
| IncomeTaxPaidSupplementalData | 207.00K | 175.00K | 180.00K | 148.00K |
| EndCashPosition | 367.01M | 342.49M | 263.18M | 316.83M |
| BeginningCashPosition | 342.49M | 263.18M | 316.83M | 250.63M |
| ChangesInCash | 24.52M | 79.31M | -53.65M | 66.19M |
| FinancingCashFlow | 4.65M | 4.55M | 11.83M | 725.28M |
| CashFlowFromContinuingFinancingActivities | 4.65M | 4.55M | 11.83M | 725.28M |
| NetOtherFinancingCharges | -70.00K | -758.00K | -32.34M | |
| NetCommonStockIssuance | 4.65M | 4.62M | 12.59M | 423.21M |
| CommonStockIssuance | 4.65M | 4.62M | 12.59M | 423.21M |
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | 334.41M | |
| NetLongTermDebtIssuance | 0.00 | 0.00 | 334.41M | |
| LongTermDebtPayments | 0.00 | 0.00 | ||
| LongTermDebtIssuance | 0.00 | 0.00 | 334.41M | |
| InvestingCashFlow | 12.86M | 76.71M | 517.00K | -632.37M |
| CashFlowFromContinuingInvestingActivities | 12.86M | 76.71M | 517.00K | -632.37M |
| NetOtherInvestingChanges | 12.10M | -15.00M | ||
| NetInvestmentPurchaseAndSale | 53.92M | 105.46M | 19.31M | -133.82M |
| SaleOfInvestment | 53.92M | 112.22M | 116.92M | 62.97M |
| PurchaseOfInvestment | 0.00 | -6.76M | -97.61M | -196.79M |
| NetBusinessPurchaseAndSale | 0.00 | 0.00 | -419.40M | |
| PurchaseOfBusiness | 0.00 | 0.00 | -419.40M | |
| NetPPEPurchaseAndSale | -41.06M | -28.75M | -30.89M | -64.14M |
| PurchaseOfPPE | -41.06M | -28.75M | -30.89M | -64.14M |
| OperatingCashFlow | 7.02M | -1.95M | -65.99M | -26.72M |
| CashFlowFromContinuingOperatingActivities | 7.02M | -1.95M | -65.99M | -26.72M |
| ChangeInWorkingCapital | -32.63M | -25.49M | -31.70M | -4.60M |
| ChangeInOtherWorkingCapital | -3.07M | -11.19M | -16.10M | -6.30M |
| ChangeInOtherCurrentLiabilities | -6.00M | -7.62M | -8.56M | |
| ChangeInOtherCurrentAssets | -8.56M | -7.88M | ||
| ChangeInPayablesAndAccruedExpense | 5.28M | 8.47M | 2.79M | 19.32M |
| ChangeInAccruedExpense | 9.28M | 13.02M | 1.84M | |
| ChangeInPayable | -4.00M | -4.55M | 958.00K | 19.32M |
| ChangeInAccountPayable | -4.00M | -4.55M | 958.00K | 19.32M |
| ChangeInPrepaidAssets | -6.83M | -3.18M | -1.16M | -6.69M |
| ChangeInInventory | -2.70M | -454.00K | -1.10M | 1.63M |
| ChangeInReceivables | -19.31M | -11.52M | -7.58M | -4.69M |
| ChangesInAccountReceivables | -19.31M | -11.52M | -7.58M | -4.69M |
| OtherNonCashItems | 12.02M | 12.30M | 14.33M | 13.01M |
| StockBasedCompensation | 33.41M | 24.63M | 24.67M | 22.46M |
| AssetImpairmentCharge | 450.00K | 1.70M | 718.00K | 6.06M |
| DepreciationAmortizationDepletion | 72.55M | 72.58M | 69.43M | 53.35M |
| DepreciationAndAmortization | 72.55M | 72.58M | 69.43M | 53.35M |
| AmortizationCashFlow | 33.45M | 35.13M | 34.06M | 23.16M |
| AmortizationOfIntangibles | 33.45M | 35.13M | 34.06M | 23.16M |
| Depreciation | 39.10M | 37.45M | 35.37M | 30.19M |
| OperatingGainsLosses | -49.00K | 292.00K | 810.00K | -108.65M |
| EarningsLossesFromEquityInvestments | 0.00 | 0.00 | -109.26M | |
| NetIncomeFromContinuingOperations | -78.73M | -87.97M | -144.25M | -8.35M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for NEO
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|